Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial

The main objective of the French GETUG/AFU V05 VESPER randomized phase III study was to assess the efficacy of dd-MVAC and GC in term of progression-free survival in patients for whom chemotherapy has been decided, before or after surgery. A total of 500 patients have been randomized in 28 reference...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfister, Christian, Harter, Valentin, Allory, Yves, Radvanyi, François, Culine, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025084/
https://www.ncbi.nlm.nih.gov/pubmed/32083220
http://dx.doi.org/10.1016/j.conctc.2020.100536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025084/
https://www.ncbi.nlm.nih.gov/pubmed/32083220
http://dx.doi.org/10.1016/j.conctc.2020.100536

Ejemplares similares